Citius Oncology
CTOR · NASDAQ
$0.671−$0.01 (−1.47%)TodayMarket closed ·
Prev close $0.681
Who owns CTOR
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 86.9% of CTOR’s shares.
- Citius Pharmaceuticals Inc71.0%
- Armistice Capital LLC9.4%
- BofA Global Research (US)4.1%
- Bartushak (Jaime)0.9%
- Next 6 largest institutions1.5%
- All other shareholders13.1%
| Holder | Shares | % of shares |
|---|---|---|
| Citius Pharmaceuticals Inc | 66.05M | 71.04% |
| Armistice Capital LLC | 8.71M | 9.36% |
| BofA Global Research (US) | 3.84M | 4.12% |
| Bartushak (Jaime) | 825.00K | 0.89% |
| Vanguard Capital Management, LLC | 546.33K | 0.59% |
| UBS Financial Services, Inc. | 315.02K | 0.34% |
| Geode Capital Management, L.L.C. | 245.41K | 0.26% |
| Vanguard Fiduciary Trust Co | 121.91K | 0.13% |
| Independent Financial Partners | 107.42K | 0.12% |
| Citadel Advisors LLC | 90.59K | 0.10% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 370.10K | 0.40% |
| Vanguard Extended Market Index Fund | 176.22K | 0.19% |
| Fidelity Extended Market Index Fund | 98.01K | 0.11% |
| Fidelity NASDAQ Composite Index Fund | 54.73K | 0.06% |
| Fidelity Total Market Index Fund | 26.29K | 0.03% |
Short interest
Settled Sep 30, 2026
- Shares short
- 289.72K
- Days to cover
- 2.24
- % of shares outstanding
- 0.31%
- Average daily volume
- 129.39K
- Change since last report
- −43.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.